Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein ##STR00001##
This application claims the benefit of U.S. Provisional Application No. 60/464916 filed on Apr. 23, 2003 and incorporated herein by reference in its entirety.
